SARS-CoV-2 variants may seem like a scary new chapter in the pandemic, but coronavirus experts expected their arrival. Scientists in the UNC School of Medicine and Gillings School of Global Public Health are tracking the variants to learn how they differ and affect the world’s chance of ending this pandemic.
For decades, scientists warned of the potential for a global coronavirus outbreak. But when SARS-CoV-2 emerged, no therapeutics, drugs, or vaccines were readily available. The Rapidly Emerging Antiviral Drug Development Initiative (READDI) — founded by researchers at UNC and the Structural Genomics Consortium — is not only finding solutions to the COVID-19 pandemic, but also drugs and therapeutics for future viral outbreaks.
Angela Smith is an associate professor in the Department of Urology within the UNC School of Medicine and a recipient of the 2020 Hettleman Award for Artistic and Scholarly Achievement. She studies how to improve the lives of patients with bladder cancer by amplifying patient voices in research and clinical care.
While COVID-19 has shaken the world, it has also pushed society to be more innovative and creative — two attributes that have been essential to the success of researchers at UNC. Carolina students, faculty, and staff are engaged in an abundance of projects, making UNC the most cited university in the nation for coronavirus research.
Food allergies have long baffled scientists — much is still to be learned about how they develop and why certain people are more susceptible than others. Researchers at UNC may be able to answer some of these questions by studying an unusual food allergy to mammalian meat called alpha-gal syndrome.
In the past, cochlear implants were employed in people with severe hearing loss, improving their ability to hear the conversations around them. But now, studies show that these devices offer benefits to patients with mild or moderate hearing loss - a group that UNC researchers and doctors are soliciting to receive cochlear implants as part of ongoing clinical trials.
Todd Cohen and Jonathan Schisler — a neuroscientist and a heart researcher — began working together in 2016 after meeting for coffee in Marsico Hall. By combining their expertise in protein studies, they strive to develop a potential treatment for Alzheimer’s disease.
People with cerebral palsy (CP) are now living longer than they ever have before. But a longer life with CP can include more complex health issues that providers are struggling to accommodate. One physical therapist at UNC wants to change that.
Hendrée Jones is the executive director of UNC Horizons, a professor of obstetrics and gynecology in the UNC School of Medicine, and an adjunct professor in the UNC College of Arts & Sciences Department of Psychology and Neuroscience. She is an internationally recognized expert in the development and examination of both behavioral and pharmacologic treatments for at-risk pregnant women and their children.
Giselle Corbie-Smith is a social medicine professor in the UNC School of Medicine, as well as director of the Center for Health Equity Research and NC TraCS’ Community Academic Resources for Engaged Scholarship (CARES) Services. She is nationally recognized for her scholarly work on the practical and ethical issues regarding involvement of minorities in research.